Full-Time

Packaging Graphics & Product Label Specialist 3

Multiple Teams

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Sunnyvale, CA, USA

In Person

Preference will be given to qualified candidates who do not reside, or plan to reside, in the listed states.

Bachelor's

Category
Art, Graphics & Animation (1)
Required Skills
Adobe InDesign
Agile
Adobe Photoshop
SAP Products
Tableau
Adobe Illustrator

Get referred to Intuitive Surgical

See people who can refer or advise you

Requirements
  • A Bachelor of Science degree in science or equivalent is required.
  • A minimum of 4 years of product labeling and project management experience in the medical device or another regulated industry is preferred.
  • Experience with graphic design, XML-based authoring tools, and labeling or printing solution software is required.
  • Experience with label design software such as EasyLabel, NiceLabel, BarTender, or Prisym is required.
  • Experience using computer-aided design equipment and graphic tools such as Adobe Illustrator, Photoshop, and InDesign is required.
  • Strong project management skills are required.
  • Strong collaboration, problem-solving, and analytical capabilities are required.
  • Excellent written and interpersonal communication skills are required.
  • The ability to understand complex technical information and translate it into writing is required.
  • The ability to recognize critical issues, react quickly under pressure, and drive issues to closure by providing coordinated direction is required.
  • The ability to work in a team environment is required.
  • The ability to prioritize tasks and escalate appropriately while working independently is required.
  • The ability to logically reason, solve problems, and make decisions on key issues with minimal supervision is required.
  • The ability to motivate and influence others without direct authority is required.
  • Familiarity with SAP and Agile or similar software is required.
  • Proficiency with Tableau, Smartsheet, or similar project management software is required.
  • Working knowledge or experience with Agile Product Lifecycle Management or similar Product Lifecycle Management business systems in the medical device or life science industry is required.
  • High ethical, moral, and personal values in decisions, communications, actions, and interactions are required.
Responsibilities
  • Create, update, and maintain product label content and artwork iterations while managing changes in the document management system.
  • Work with Research and Development, Regulatory, Operations, Quality, Marketing, and other cross-functional team members to develop labeling content, align stakeholders, and translate content into functional label layouts using labeling or illustration software.
  • Execute and support minor requirement updates.
  • Execute minor projects independently when they require minimal content updates or changes, such as version changes.
  • Troubleshoot issues, communicate their impact, and propose solutions.
  • Support and execute complex or major design-change projects with Labeling Project Managers and engineering teams.
  • Design and execute labels using current labeling applications such as GLMS, BarTender, and Hybrid.
  • Execute required label qualifications involving attributes, tables, images, symbols, translations, training, and problem-solving assistance.
  • Support and execute company initiatives and the Quality Management System as identified by management.
  • Execute the end-to-end GLMS Change Order process.
  • Collaborate with the Label Design and Development team to produce consistent methods for developing product labels and to support business needs and manufacturing variance.
  • Communicate project risks, tactical approaches, and escalation issues clearly to direct management.
  • Provide training to peer and subordinate team members.
  • Use Product Lifecycle Management and change-control processes to troubleshoot issues and escalate them to the appropriate department.
  • Collaborate with Test Engineering, Quality, Regulatory, Project Management, Design, and Document Control to support manufacturing needs for multiple products and business units.
  • Collaborate with business-unit and Information Technology stakeholders to develop labeling solutions.
  • Develop tools supporting tactical business transformation programs.
  • Coordinate User Acceptance Testing activities with Information Technology and business partners for product label content.
  • Contribute to solutions and best practices for labeling initiatives.
  • Ensure timely completion of department projects and communicate constraints when completion is at risk.
  • Perform a broad variety of tasks supporting global labeling as assigned by department management.
Desired Qualifications
  • Experience with product labeling and project management in the medical device or another regulated industry.
  • Experience with Change Management or document control.
  • Experience in Adobe Illustrator and Photoshop or prior experience with label creation software such as BarTender or Prisym.

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 19% to $2.89 billion, beating estimates on July 16.
  • Penang lease adds 316,000 square feet and 1,200 jobs, supporting Asia-Pacific growth.
  • Management kept 2026 da Vinci growth at 13.5%-15.5% and raised gross-margin guidance.

What critics are saying

  • FDA recall tracker listed multiple 2026 da Vinci Class II recalls, signaling quality-control strain.
  • Medtronic Hugo gained U.S. urology clearance in December 2025, tightening robotic-surgery competition.
  • 2027 extended instrument-use changes risk recurring revenue erosion if hospitals delay upgrades.

What makes Intuitive Surgical unique

  • Da Vinci installed base neared 13,000 systems worldwide, locking in switching costs.
  • Da Vinci 5 launched broadly in the U.S. in 2025, boosting utilization.
  • Ion procedures grew 36% in Q2 2026, extending Intuitive beyond soft-tissue robotics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.

PR Newswire
Aug 17th, 2026
Intuitive leases 316,000-sq-ft facility in Penang to manufacture surgical instruments, create 1,200 jobs by 2032

Intuitive, the global leader in minimally invasive care and pioneer of robotic-assisted surgery, has signed a lease agreement with Penang Development Corporation for a new manufacturing facility in Malaysia. The 316,000-square-foot site in Bandar Cassia Technology Park will produce surgical instruments and electromechanical devices for Intuitive's da Vinci surgical system. The facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032. The investment reflects Intuitive's commitment to Asia Pacific, where its da Vinci systems have treated more than 2.5 million patients across 13 markets over two decades. The expansion aims to support growing demand for robotic-assisted surgery across the region and strengthen Penang's position as a MedTech manufacturing hub in Southeast Asia.

Yahoo Finance
Aug 16th, 2026
Oppenheimer upgrades Intuitive Surgical to 'Outperform' with $500 price target

Oppenheimer upgraded Intuitive Surgical from "Perform" to "Outperform" with a $500 price target, implying a 24.6% upside. The analysts expect the medtech company to maintain its leading position in robotic surgery despite increasing competition. Intuitive reported strong Q2 results, with revenue rising 18.5% year-over-year to $2.89 billion, surpassing analyst expectations. Non-GAAP earnings per share climbed 27.9% to $2.80, beating the $2.50 estimate. The company placed 468 da Vinci surgical systems and 55 Ion endoluminal systems during the quarter. Combined da Vinci and Ion procedures rose approximately 16% globally. Wall Street maintains a "Strong Buy" consensus rating on the stock, with 22 of 31 analysts recommending a strong buy. The consensus price target of $480.93 represents a 19.85% upside.

Yahoo Finance
Aug 12th, 2026
Intuitive Surgical's valuation barely budges despite two years of growth forecasts

Intuitive Surgical trades at $401.23, down 32% from its 52-week high and 15% over twelve months. The stock currently trades at 37.7 times trailing adjusted earnings. Analysts forecast earnings of $12.08 per share by 2027, bringing the multiple down to 33 times — only 13% lower despite two years of growth. Consensus projects 7% annual earnings growth and 9.7% revenue growth, suggesting margin compression ahead. Management raised its 2026 gross profit margin guidance to 68-69%. However, the company plans to extend instrument use limits starting in the first half of 2027 to lower procedure costs and boost adoption. Intuitive has not finalised pricing for this programme, creating uncertainty around 2027 estimates. The company will quantify the impact on its next earnings call.

Yahoo Finance
Aug 8th, 2026
Medtronic and Intuitive Surgical lag market amid sector weakness

Medtronic and Intuitive Surgical, two medical device leaders, have underperformed this year due to sector weakness and company-specific challenges. However, both show potential for recovery. Medtronic's fourth-quarter revenue rose 9.9% to $9.8 billion, though adjusted earnings per share fell 4.3% to $1.55 due to higher costs, including tariffs. The company posted its highest annual revenue growth in a decade, driven partly by its Pulse Field Ablation franchise. Medtronic recently received FDA clearance for its Hugo robotic-assisted surgery system for urologic procedures, positioning it to compete in the underpenetrated robotic surgery market. The company plans to spin off its lower-margin diabetes care division, which should improve margins. With a 3.4% forward dividend yield and 49 consecutive years of payout increases, Medtronic appeals to income-focused investors.